We are live on ! Find out more
LICN icon

Lichen China

1 hedge funds and large institutions have $30.8K invested in Lichen China in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,675% more capital inflows, than outflows

Capital inflows: $36K | Capital outflows: $1.3K

0.19% more ownership

Funds ownership: 0% → 0.2% (+0.19%)

0% more funds holding

Funds holding: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$36K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$1.3K

LICN Hedge Fund Activity: Q1 2024 in Review

1 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in Lichen China (LICN) for Q1 2024, worth a combined $30.8K — up 2,274% from $1.3K a quarter earlier.

Fund positioning in LICN was balanced in Q1 2024: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $36K. The largest seller was UBS Group, exiting entirely with an estimated $1.3K sold.

  • 1 institutional investor held Lichen China (LICN) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $30.8K of Lichen China stock for Q1 2024, up 2,274% quarter-over-quarter.
  • 1 fund opened new Lichen China positions in Q1 2024 and 1 closed out, a net change of 0 holders.
  • The largest Lichen China buyer in Q1 2024 was Susquehanna International Group, an estimated $36K added.
  • The largest Lichen China seller in Q1 2024 was UBS Group, an estimated $1.3K sold.

Based on aggregated 13F filings for Q1 2024.